Enrico Bentivegna

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 29

Top Topics

Coronavirus Disease

Acinetobacter Baumannii

Top Venues

International journal of environmental research and public health

Expert review of neurotherapeutics

SN comprehensive clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Enrico Bentivegna, Dilara Onan, Paolo Martelletti
Unmet Needs in Preventive Treatment of Migraine. Neurology and therapy (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Dilara Onan, William David Wells-Gatnik, Enrico Bentivegna, Christian Lampl, Paolo Martelletti
New Migraine Drugs for Older Adults. Drugs & aging (2023)
Enrico Bentivegna, Silvia Galastri, Dilara Onan, Paolo Martelletti
Unmet Needs in the Acute Treatment of Migraine. Advances in therapy (2023)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Enrico Bentivegna, Silvia Di Meo, Anita Carriero, Nadia Capriotti, Alberto Barbieri, Paolo Martelletti
Access to COVID-19 Vaccination during the Pandemic in the Informal Settlements of Rome. International journal of environmental research and public health 19 (2) (2022)
Enrico Bentivegna, Cristina Tassorelli, Roberto De Icco, Grazia Sances, Paolo Martelletti
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes. Expert review of neurotherapeutics 22 (3) (2022)
Fidel Dominique Festin Ambat, Enrico Bentivegna, Paolo Martelletti
Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (3) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Paolo Martelletti, Enrico Bentivegna
Insights into headache 2022. Expert review of neurotherapeutics 22 (2) (2022)
Enrico Bentivegna, Michelangelo Luciani, Valeria Ferrari, Silvia Galastri, Francesco Baldari, Francesco Scarso, Piera A Lamberti, Paolo Martelletti
Recently approved and emerging drug options for migraine prophylaxis. Expert opinion on pharmacotherapy 23 (11) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Silvia Benemei, Enrico Bentivegna, Paolo Martelletti
Positioning the new drugs for migraine. Expert opinion on drug metabolism & toxicology 18 (1) (2022)
Michelangelo Luciani, Andrea Negro, Valerio Spuntarelli, Enrico Bentivegna, Paolo Martelletti
Evaluating and managing severe headache in the emergency department. Expert review of neurotherapeutics 21 (3) (2021)
Paolo Martelletti, Michelangelo Luciani, Valerio Spuntarelli, Enrico Bentivegna
Deprescribing in migraine. Expert opinion on drug safety 20 (6) (2021)
Enrico Bentivegna, Michelangelo Luciani, Francesco Scarso, Clara Bruscia, Dario Chiappino, Emanuele Amore, Gabriele Nalli, Paolo Martelletti
Hormonal therapies in migraine management: current perspectives on patient selection and risk management. Expert review of neurotherapeutics (2021)
Silvia Di Meo, Enrico Bentivegna
Migrants' Quarantine and COVID-19 Pandemic in Italy: a Medico-anthropological View. SN comprehensive clinical medicine (2021)
Enrico Bentivegna, Michelangelo Luciani, Vincenzo Paragliola, Francesco Baldari, Piera A Lamberti, Giulia Conforti, Valerio Spuntarelli, Paolo Martelletti
Recent advancements in tension-type headache: a narrative review. Expert review of neurotherapeutics 21 (7) (2021)
Enrico Bentivegna, Michelangelo Luciani, Luca Arcari, Iolanda Santino, Maurizio Simmaco, Paolo Martelletti
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study. International journal of environmental research and public health 18 (3) (2021)
Valerio Spuntarelli, Andrea Negro, Michelangelo Luciani, Enrico Bentivegna, Paolo Martelletti
Eptinezumab for the treatment of migraine. Expert opinion on biological therapy 21 (8) (2021)
Michelangelo Luciani, Enrico Bentivegna, Valerio Spuntarelli, Piera Amoriello Lamberti, Giulio Cacioli, Flavia Del Porto, Giorgio Sesti, Paolo Martelletti, Luciano De Biase
Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? Journal of medical virology 93 (4) (2020)
Enrico Bentivegna, Alberto Sentimentale, Michelangelo Luciani, Maria Letizia Speranza, Ludovica Guerritore, Paolo Martelletti
New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient. Journal of medical virology 93 (1) (2020)
Enrico Bentivegna, M Luciani, V Spuntarelli, M L Speranza, L Guerritore, A Sentimentale, P Martelletti
Extremely Severe Case of COVID-19 Pneumonia Recovered Despite Bad Prognostic Indicators: a Didactic Report. SN comprehensive clinical medicine (2020)